| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701394 | Journal of Cancer Policy | 2017 | 7 Pages |
Abstract
There was reasonable agreement between ESMO-MCBS and the AMNOG. Although there was a statistically significant correlation between the scale and ASMR scores overall there is very little agreement between the two categories in the middle of the scale. The link between ESMO-MCBS and QALYs appears to be very weak with very little differentiation between drugs receiving a ESMO-MCBS of 2, 3 or 4.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Peter Lindgren, Bengt Jönsson, Nils Wilking,